Target intelligence / Profile preview

Cell-surface receptors and glycoconjugates used by the AAV capsid

Molecular classification
Receptor, Glycoconjugate, Proteoglycan, G protein-coupled receptor, Transmembrane protein
01

Overview

The cell-surface receptors and glycoconjugates used by the adeno-associated virus (AAV) capsid are a heterogeneous group of host factors that mediate the complex process of viral entry. This process typically begins with a primary attachment to cell-surface glycans, which serve as attachment factors to concentrate the virus on the cell membrane. Specific glycans are utilized by different AAV serotypes: heparan sulfate proteoglycans (HSPG) for AAV2, AAV3, and AAV6; sialic acid for AAV1, AAV4, AAV5, and AAV6; and galactose for AAV9 (Asokan et al., 2012, Molecular Therapy). Following attachment, the virus engages essential protein receptors for internalization, most notably the Adeno-associated virus receptor (AAVR, also known as KIAA0319L), which is a universal entry factor for most AAV serotypes (Pillay et al., 2016, Nature). Other critical factors include GPR108 and various co-receptors such as FGFR1, integrins, and the laminin receptor (Dudek et al., 2020, Molecular Therapy). These interactions are the primary determinants of AAV tissue tropism and are exploited in the design of AAV-based gene therapies to deliver genetic material to specific target tissues. Understanding the molecular basis of these interactions is crucial for optimizing vector efficiency and overcoming challenges such as pre-existing immunity and off-target transduction (NIH, 2021).

Other names
AAV entry factorsAAV attachment factorsAdeno-associated virus receptorAAVRKIAA0319LHeparan sulfate proteoglycanHSPGSialic acidGalactoseGPR108
02

Mechanism of action

Mediation of viral attachment and entry into host cells via receptor-mediated endocytosis.

03

Biological functions

Viral entryEndocytosisCell-virus interactionIntracellular traffickingCell adhesion
04

Disease associations

InfectionGenetic disease
05

Safety considerations

Off-target transductionPre-existing immunityReceptor saturationTissue tropism variabilityImmunogenicity
06

Interacting drugs

Onasemnogene abeparvovec

7 more in the full profile.

07

Biomarkers

AAVR expressionHSPG expressionSialic acid levelsGalactose levels

Beyond the preview

Go deeper on Cell-surface receptors and glycoconjugates used by the AAV capsid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cell-surface receptors and glycoconjugates used by the AAV capsid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call